Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$3.04 - $5.14 $47,424 - $80,184
-15,600 Reduced 27.42%
41,300 $4,000
Q2 2022

Aug 04, 2022

SELL
$3.17 - $6.17 $41,844 - $81,444
-13,200 Reduced 18.83%
56,900 $3,000
Q1 2022

Apr 14, 2022

BUY
$4.16 - $13.72 $271,648 - $895,916
65,300 Added 1360.42%
70,100 $18,000
Q4 2021

Jan 18, 2022

BUY
$10.83 - $18.41 $46,569 - $79,163
4,300 Added 860.0%
4,800 $4,000
Q2 2020

Jul 22, 2020

SELL
$16.86 - $23.44 $65,754 - $91,416
-3,900 Reduced 88.64%
500 $0
Q1 2020

May 07, 2020

BUY
$14.47 - $27.96 $36,175 - $69,900
2,500 Added 131.58%
4,400 $5,000
Q1 2019

May 10, 2019

SELL
$31.58 - $46.35 $341,064 - $500,580
-10,800 Reduced 85.04%
1,900 $2,000
Q4 2018

Feb 05, 2019

SELL
$30.43 - $56.65 $130,849 - $243,595
-4,300 Reduced 25.29%
12,700 $13,000
Q3 2018

Nov 07, 2018

SELL
$46.46 - $68.49 $566,812 - $835,577
-12,200 Reduced 41.78%
17,000 $266,000
Q2 2018

Aug 10, 2018

BUY
$46.25 - $104.45 $411,625 - $929,605
8,900 Added 43.84%
29,200 $186,000
Q1 2018

May 11, 2018

SELL
$57.4 - $108.44 $361,620 - $683,172
-6,300 Reduced 23.68%
20,300 $1.09 Million
Q4 2017

Jan 17, 2018

SELL
$23.02 - $60.5 $43,738 - $114,950
-1,900 Reduced 6.67%
26,600 $538,000
Q3 2017

Oct 17, 2017

BUY
$17.79 - $24.0 $507,015 - $684,000
28,500
28,500 $45,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $187M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.